Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Jennifer Grossman, MD

UCLA
Sherman Oaks, CA, United States

Clinical Professor, Adult Rheumatology Fellowship Program Director

Presentation(s):

  • 2025 ACR Guidelines for the Treatment of Extrarenal Systemic Lupus Erythematosus (SLE)

    Sunday, October 26, 2025
    9:00 AM – 10:30 AM Central Time

    Disclosure(s): american board of internal medicine: Advisor or Review Panel Member (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); exact sciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing); ilumina: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); iqvia: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Lupus Foundation of America: Officer or Board Member (Ongoing); Merck/MSD: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); rheumatology research foundation: Grant/Research Support (Ongoing)

  • Tackling the Burning Question of Peripheral Neuropathies in Sjögren's Disease: New Guidelines

    Sunday, October 26, 2025
    10:30 AM – 11:30 AM Central Time

    Disclosure(s): american board of internal medicine: Advisor or Review Panel Member (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); exact sciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing); ilumina: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); iqvia: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Lupus Foundation of America: Officer or Board Member (Ongoing); Merck/MSD: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); rheumatology research foundation: Grant/Research Support (Ongoing)

  • Oh Baby! Reproductive Health in Antiphospholipid Syndrome, Sjögren's and Systemic Lupus Erythematosus

    Sunday, October 26, 2025
    1:00 PM – 2:30 PM Central Time

    Disclosure(s): american board of internal medicine: Advisor or Review Panel Member (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); exact sciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing); ilumina: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); iqvia: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Lupus Foundation of America: Officer or Board Member (Ongoing); Merck/MSD: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); rheumatology research foundation: Grant/Research Support (Ongoing)

  • Fake Rheum: Case-Based Approach to Rheumatology Mimics

    Monday, October 27, 2025
    4:00 PM – 5:00 PM Central Time

    Disclosure(s): american board of internal medicine: Advisor or Review Panel Member (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); exact sciences: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing); ilumina: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); iqvia: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Lupus Foundation of America: Officer or Board Member (Ongoing); Merck/MSD: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); rheumatology research foundation: Grant/Research Support (Ongoing)